The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Epigenetics in hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and has a high fatality rate. Genetic and epigenetic aberrations are commonly observed in HCC. The epigenetic processes include chromatin remodelling, histone alterations, DNA methylation, and noncoding RNA (ncRNA) expression and are connected with the progression and metastasis of HCC. Due to their potential reversibility, these epigenetic alterations are widely targeted for the development of biomarkers. In-depth understanding of the epigenetics of HCC is critical for developing rational clinical strategies that can provide a meaningful improvement in overall survival and prediction of therapeutic outcomes. In this article, we have summarised the epigenetic modifications involved in HCC progression and highlighted the potential biomarkers for diagnosis and drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Zhang, X., Wang, S., Wang, H., Cao, J., Huang, X., Chen, Z., Xu, P., Sun, G., Xu, J., Lv, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-018-0935-5 · Cited by 842
RetractedZhang, H., Deng, T., Ge, S., Liu, Y., Bai, M., Zhu, K., Fan, Q., Li, J., Ning, T., Tian, F., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0619-z · Cited by 303
RetractedRong, D., Lu, C., Zhang, B., Fu, K., Zhao, S., Tang, W., & Cao, H. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0958-6 · Cited by 240
RetractedTang, B., Qi, G., Tang, F., Yuan, S., Wang, Z., Liang, X., Li, B., Yu, S., Liu, J., Huang, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3713 · Cited by 77
RetractedRegulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462
The Biogenesis, Functions, and Challenges of Circular RNAs
Li, X., Yang, L., & Chen, L.-L. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.034 · Cited by 2,062
Non-coding RNA networks in cancer
Anastasiadou, E., Jacob, L. S., & Slack, F. J. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.99 · Cited by 1,884
Towards a molecular understanding of microRNA-mediated gene silencing
Jonas, S., & Izaurralde, E. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3965 · Cited by 1,872
Functions of Site-Specific Histone Acetylation and Deacetylation
Shahbazian, M. D., & Grunstein, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.052705.162114 · Cited by 1,635
The role of non-coding RNAs in oncology
Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619
Zhang, Y., & Reinberg, D. (2001) · Genes & Development · doi:10.1101/gad.927301 · Cited by 1,530
Cellular functions of long noncoding RNAs
Yao, R.-W., Wang, Y., & Chen, L.-L. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0311-8 · Cited by 1,386
Chen, M., Wei, L., Law, C., Tsang, F. H., Shen, J., Cheng, C. L., Tsang, L., Ho, D. W., Chiu, D. K., Lee, J. M., et al. (2018) · Hepatology · doi:10.1002/hep.29683 · Cited by 1,376
Writing, erasing and reading histone lysine methylations
Hyun, K., Jeon, J., Park, K., & Kim, J. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.11 · Cited by 1,250
Circular RNAs function as ceRNAs to regulate and control human cancer progression
Zhong, Y., Du, Y., Yang, X., Mo, Y., Fan, C., Xiong, F., Ren, D., Ye, X., Li, C., Wang, Y., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0827-8 · Cited by 1,007
Topological-insulator-based terahertz modulator
Wang, X. B., Cheng, L., Wu, Y., Zhu, D. P., Wang, L., Zhu, J.-X., Yang, H., & Chia, E. E. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-13701-9 · Cited by 978
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
Feinberg, A. P., Koldobskiy, M. A., & Göndör, A. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.13 · Cited by 841
The many faces of histone lysine methylation
Lachner, M., & Jenuwein, T. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00335-6 · Cited by 819
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
Marengo, A., Rosso, C., & Bugianesi, E. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-090514-013832 · Cited by 755
Circular RNA identification based on multiple seed matching
Gao, Y., Zhang, J., & Zhao, F. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbx014 · Cited by 701
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer
Braconi, C., Kogure, T., Valeri, N., Huang, N., Nuovo, G., Costinean, S., Negrini, M., Miotto, E., Croce, C. M., & Patel, T. (2011) · Oncogene · doi:10.1038/onc.2011.193 · Cited by 642
Chen, Y., Peng, C., Chen, J., Chen, D., Yang, B., He, B., Hu, W., Zhang, Y., Liu, H., Dai, L., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1053-8 · Cited by 630
Towards a complete map of the human long non-coding RNA transcriptome
Uszczynska-Ratajczak, B., Lagarde, J., Frankish, A., Guigó, R., & Johnson, R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0017-y · Cited by 616
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China
Shen, T., Liu, Y., Shang, J., Xie, Q., Li, J., Yan, M., Xu, J., Niu, J., Liu, J., Watkins, P. B., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.02.002 · Cited by 615
Epigenetic modifications of histones in cancer
Zhao, Z., & Shilatifard, A. (2019) · Genome Biology · doi:10.1186/s13059-019-1870-5 · Cited by 552
Kamiya, Y., Ge, L., Hong, T., Qiu, Y., Quintero-Castro, D. L., Lu, Z., Cao, H. B., Matsuda, M., Choi, E. S., Batista, C. D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05679-3 · Cited by 529
Clinical epigenetics: seizing opportunities for translation
Berdasco, M., & Esteller, M. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0074-2 · Cited by 498
Understanding nucleosome dynamics and their links to gene expression and DNA replication
Lai, W. K. M., & Pugh, B. F. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.47 · Cited by 495
Yang, F., Huo, X.-S., Yuan, S.-X., Zhang, L., Zhou, W.-P., Wang, F., & Sun, S.-H. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.010 · Cited by 477
Chen, Y., Wang, D., Peng, H., Chen, X., Han, X., Yu, J., Wang, W., Liang, L., Liu, Z., Zheng, Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-018-0930-x · Cited by 439
DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma
Villanueva, A., Portela, A., Sayols, S., Battiston, C., Hoshida, Y., Méndez‐González, J., Imbeaud, S., Letouzé, E., Hernandez‐Gea, V., Cornella, H., et al. (2015) · Hepatology · doi:10.1002/hep.27732 · Cited by 428
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
Wong, C.-M., Tsang, F. H.-C., & Ng, I. O.-L. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.169 · Cited by 424
Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy
Biswas, S., & Rao, C. M. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.021 · Cited by 389
Cui, M., Xiao, Z., Wang, Y., Zheng, M., Song, T., Cai, X., Sun, B., Ye, L., & Zhang, X. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1192 · Cited by 369
Shang, X., Li, G., Liu, H., Li, T., Liu, J., Zhao, Q., & Wang, C. (2016) · Medicine · doi:10.1097/md.0000000000003811 · Cited by 330
MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer
Zhang, Y., Guo, L., Li, Y., Feng, G.-H., Teng, F., Li, W., & Zhou, Q. (2018) · Molecular Cancer · doi:10.1186/s12943-017-0753-1 · Cited by 326
Lin, X.-J., Chong, Y., Guo, Z.-W., Xie, C., Yang, X.-J., Zhang, Q., Li, S.-P., Xiong, Y., Yuan, Y., Min, J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00048-0 · Cited by 276
XX sex chromosome complement promotes atherosclerosis in mice
AlSiraj, Y., Chen, X., Thatcher, S. E., Temel, R. E., Cai, L., Blalock, E., Katz, W., Ali, H. M., Petriello, M., Deng, P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10462-z · Cited by 268
Targeting Epigenetics in Cancer
Bennett, R. L., & Licht, J. D. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-105106 · Cited by 246
Wei, Y., Chen, X., Liang, C., Ling, Y., Yang, X., Ye, X., Zhang, H., Yang, P., Cui, X., Ren, Y., et al. (2020) · Hepatology · doi:10.1002/hep.30795 · Cited by 244
Arechederra, M., Daian, F., Yim, A., Bazai, S. K., Richelme, S., Dono, R., Saurin, A. J., Habermann, B. H., & Maina, F. (2018) · Nature Communications · doi:10.1038/s41467-018-05550-5 · Cited by 221
Xu, L., Feng, X., Hao, X., Wang, P., Zhang, Y., Zheng, X., Li, L., Ren, S., Zhang, M., & Xu, M. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1041-2 · Cited by 213
Wang, G., Liu, W., Zou, Y., Wang, G., Deng, Y., Luo, J., Zhang, Y., Li, H., Zhang, Q., Yang, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.062 · Cited by 212
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
Ding, X., He, M., Chan, A. W. H., Song, Q. X., Sze, S. C., Chen, H., Man, M. K. H., Man, K., Chan, S. L., Lai, P. B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.09.005 · Cited by 207
Hernandez-Vargas, H., Lambert, M.-P., Le Calvez-Kelm, F., Gouysse, G., McKay-Chopin, S., Tavtigian, S. V., Scoazec, J.-Y., & Herceg, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009749 · Cited by 199
Horie, T., Ono, K., Nishi, H., Iwanaga, Y., Nagao, K., Kinoshita, M., Kuwabara, Y., Takanabe, R., Hasegawa, K., Kita, T., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.136 · Cited by 186
Dai, X., Chen, C., Yang, Q., Xue, J., Chen, X., Sun, B., Luo, F., Liu, X., Xiao, T., Xu, H., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0485-1 · Cited by 184
piRNA Biogenesis in Drosophila melanogaster
Huang, X., Fejes Tóth, K., & Aravin, A. A. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.09.002 · Cited by 181
Zhao, L., Han, T., Li, Y., Sun, J., Zhang, S., Liu, Y., Shan, B., Zheng, D., & Shi, J. (2017) · The FASEB Journal · doi:10.1096/fj.201600994r · Cited by 179
Fu, L., Yao, T., Chen, Q., Mo, X., Hu, Y., & Guo, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16881 · Cited by 178
Epigenetic mechanisms in hepatocellular carcinoma: How environmental factors influence the epigenome
Herceg, Z., & Paliwal, A. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.04.001 · Cited by 171
Bugide, S., Green, M. R., & Wajapeyee, N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802691115 · Cited by 164
Yang, G., Yuan, Y., Yuan, H., Wang, J., Yun, H., Geng, Y., Zhao, M., Li, L., Weng, Y., Liu, Z., et al. (2021) · EMBO reports · doi:10.15252/embr.202050967 · Cited by 164
Wei, L., Chiu, D. K.-C., Tsang, F. H.-C., Law, C.-T., Cheng, C. L.-H., Au, S. L.-K., Lee, J. M.-F., Wong, C. C.-L., Ng, I. O.-L., & Wong, C.-M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.015 · Cited by 163
Aberrant Super‐Enhancer Landscape in Human Hepatocellular Carcinoma
Tsang, F. H., Law, C., Tang, T. C. C., Cheng, C. L., Chin, D. W., Tam, V., Wei, L., Wong, C. C., Ng, I. O., & Wong, C. (2019) · Hepatology · doi:10.1002/hep.30544 · Cited by 161
Lü, M., Zhu, W., Wang, X., Tang, J.-J., Zhang, K., Yu, G., Shao, W., Lin, Z., Wang, S.-H., Lu, L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.019 · Cited by 150
Schroeder, F. A., Lewis, M. C., Fass, D. M., Wagner, F. F., Zhang, Y.-L., Hennig, K. M., Gale, J., Zhao, W.-N., Reis, S., Barker, D. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071323 · Cited by 146
Salerno, D., Chiodo, L., Alfano, V., Floriot, O., Cottone, G., Paturel, A., Pallocca, M., Plissonnier, M., Jeddari, S., Belloni, L., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319637 · Cited by 145
Bitzer, M., Horger, M., Giannini, E. G., Ganten, T. M., Wörns, M., Siveke, J. T., Dollinger, M., Gerken, G., Scheulen, M. E., Wege, H., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.043 · Cited by 139
Cai, M.-Y., Hou, J.-H., Rao, H., Luo, R.-Z., Li, M., Pei, X., Lin, M. C. M., Guan, X., Kung, H., Zeng, Y.-X., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00103 · Cited by 136
He, C., Xu, J., Zhang, J., Xie, D., Ye, H., Xiao, Z., Cai, M., Xu, K., Zeng, Y., Li, H., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.11.003 · Cited by 134
Epigenetics of hepatocellular carcinoma
Toh, T. B., Lim, J. J., & Chow, E. K. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0230-0 · Cited by 134
Bárcena‐Varela, M., Caruso, S., Llerena, S., Álvarez‐Sola, G., Uriarte, I., Latasa, M. U., Urtasun, R., Rebouissou, S., Alvarez, L., Jimenez, M., et al. (2019) · Hepatology · doi:10.1002/hep.30168 · Cited by 130
The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4
Sandbothe, M., Buurman, R., Reich, N., Greiwe, L., Vajen, B., Gürlevik, E., Schäffer, V., Eilers, M., Kühnel, F., Vaquero, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.004 · Cited by 127
Notch3 Functions as a Tumor Suppressor by Controlling Cellular Senescence
Cui, H., Kong, Y., Xu, M., & Zhang, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3902 · Cited by 126
Freese, K., Seitz, T., Dietrich, P., Lee, S. M. L., Thasler, W. E., Bosserhoff, A., & Hellerbrand, C. (2019) · Cancers · doi:10.3390/cancers11101587 · Cited by 124
The Epigenetic Regulation of HCC Metastasis
Han, T., Ban, H. S., Hur, K., & Cho, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123978 · Cited by 122
Feng, Y., Liao, Y., Huang, W., Lai, X., Luo, J., Du, C., Lin, J., Zhang, Z., Qiu, D., Liu, Q., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0734-3 · Cited by 121
Yuan, W., Lao, X., Xiao, C., Wang, X., Wu, Z.-J., Zeng, Q., Wu, C.-Y., Wu, R., Chen, Z.-X., Zheng, L., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.250 · Cited by 120
Quint, K., Agaimy, A., Fazio, P. D., Montalbano, R., Steindorf, C., Jung, R., Hellerbrand, C., Hartmann, A., Sitter, H., Neureiter, D., et al. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1103-0 · Cited by 119
Chan, L.-H., Zhou, L., Ng, K. Y., Wong, T. L., Lee, T. K., Sharma, R., Loong, J. H. C., Ching, Y. P., Yuan, Y., Xie, D., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.053 · Cited by 116
Alcohol and hepatocarcinogenesis
Taniai, M. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0203 · Cited by 116
Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
Song, M.-A., Tiirikainen, M., Kwee, S., Okimoto, G., Yu, H., & Wong, L. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055761 · Cited by 115
DNA demethylation and invasive cancer: implications for therapeutics
Cheishvili, D., Boureau, L., & Szyf, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12885 · Cited by 113
Xiong, L., Wu, F., Wu, Q., Xu, L., Cheung, O. K.-W., Kang, W., Mok, M. T. S., Szeto, L. L. M., Lun, C.-Y., Lung, R. W. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08245-z · Cited by 111
Epigenetic reprogramming in liver fibrosis and cancer
Wilson, C. L., Mann, D. A., & Borthwick, L. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.011 · Cited by 106
JARID1 Histone Demethylases: Emerging Targets in Cancer
Harmeyer, K. M., Facompre, N. D., Herlyn, M., & Basu, D. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.08.004 · Cited by 104
Andersen, J. B., Factor, V. M., Marquardt, J. U., Raggi, C., Lee, Y.-H., Seo, D., Conner, E. A., & Thorgeirsson, S. S. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001338 · Cited by 103
Yang, H. J., Jin, X., Yan, Y., Shao, Y., Pan, Y., Roberts, L. R., Zhang, J., Huang, H., & Jiang, J. (2017) · Scientific Reports · doi:10.1038/srep43864 · Cited by 103
Integrating the Epigenome to Identify Drivers of Hepatocellular Carcinoma
Hlady, R. A., Sathyanarayan, A., Thompson, J. J., Zhou, D., Wu, Q., Pham, K., Lee, J., Liu, C., & Robertson, K. D. (2019) · Hepatology · doi:10.1002/hep.30211 · Cited by 102
MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer
Bae, H. J., Jung, K. H., Eun, J. W., Shen, Q., Kim, H. S., Park, S. J., Shin, W. C., Yang, H. D., Park, W. S., Lee, J. Y., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.019 · Cited by 99
PI3-K/Akt pathway contributes to IL-6-dependent growth of 7TD1 cells
Zhang, J., Li, Y., & Shen, B. (2003) · Cancer Cell International · doi:10.1186/1475-2867-3-1 · Cited by 95
Xu, F. L., Zha, G., Wu, Y., Cai, W., & Ao, J. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s182005 · Cited by 94
Zhao, T., Huan, Q., Sun, J., Liu, C., Hou, X., Yu, X., Silverman, I. M., Zhang, Y., Gregory, B. D., Liu, C., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1799-8 · Cited by 94
LER, S. Y., Leung, C. H., Khin, L. W., Lu, G., Salto‐Tellez, M., Hartman, M., Iau, P. T. C., Yap, C. T., & Hooi, S. C. (2015) · Oncology Reports · doi:10.3892/or.2015.4263 · Cited by 92
MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling
Cao, L., Liu, Y., Wang, D., Huang, L. J., Li, F., Liu, J., Zhang, C., Shen, Z., Gao, Q., Yuan, W., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0757-8 · Cited by 88
Jueliger, S., Lyons, J. F., Cannito, S., Pata, I., Pata, P., Školnaja, M., Re, O. L., Peyrou, M., Villarroya, F., Pazienza, V., et al. (2016) · Epigenetics · doi:10.1080/15592294.2016.1214781 · Cited by 87
Jeltsch, A., Broche, J., & Bashtrykov, P. (2018) · Genes · doi:10.3390/genes9110566 · Cited by 87
Lv, J., Kong, Y., Gao, Z., Liu, Y., Zhu, P., & Yu, Z. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.05.010 · Cited by 84
Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma
Li, G., Xu, W., Zhang, L., Liu, T., Jin, G.-N., Song, J., Wu, J., Wang, Y., Chen, W., Zhang, C., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.064 · Cited by 83
Cheng, C., Wang, Q., Zhu, M., Liu, K., & Zhang, Z. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0846-6 · Cited by 81
Lin, Q., Wu, Z., Yue, X., Yu, X., Wang, Z., Song, X., Xu, L., He, Y., Ge, Y., Tan, S., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102676 · Cited by 81
Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells
Gailhouste, L., Liew, L. C., Yasukawa, K., Hatada, I., Tanaka, Y., Nakagama, H., & Ochiya, T. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.04.018 · Cited by 80
Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective
Tsilimigras, D. I., Ntanasis‐Stathopoulos, I., Moris, D., Spartalis, E. D., & Pawlik, T. M. (2018) · Surgical Oncology · doi:10.1016/j.suronc.2018.07.015 · Cited by 80
Ma, C., Wang, F., Han, B., Zhong, X., Si, F., Ye, J., Hsueh, E. C., Robbins, L., Kiefer, S. M., Zhang, Y., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0824-y · Cited by 79
Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma
Hong, Y. K., Li, Y., Pandit, H., Li, S., Pulliam, Z., Zheng, Q., Yu, Y., & Martin, R. C. G. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2018.12.010 · Cited by 78
MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling
Jiang, L., Liu, J.-Y., Shi, Y., Tang, B., He, T., Liu, J., Fan, J., Wu, B. Y., Xu, X., Zhao, Y., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1186-z · Cited by 77
Zhang, Y., Zhu, Z., Huang, S., Zhao, Q., Huang, C., Tang, Y., Sun, C., Zhang, Z., Wang, L., Chen, H., et al. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0909-8 · Cited by 75
Role of Epigenetics in Cancer Initiation and Progression
Chik, F., Szyf, M., & Rabbani, S. A. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0254-1_8 · Cited by 74
Liu, M., Zhang, L., Li, H., Hinoue, T., Zhou, W., Ohtani, H., El-Khoueiry, A. B., Daniels, J. R., O'Connell, C. L., Dorff, T. B., et al. (2018) · Hepatology · doi:10.1002/hep.30091 · Cited by 74
Gao, X., Sheng, Y., Yang, J. L., Wang, C., Zhang, R., Zhu, Y., Zhang, Z., Zhang, K., Yan, S., Sun, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0832-1 · Cited by 74
Han, P., Li, H., Jiang, X. L., Zhai, B., Tan, G., Zhao, D., Qiao, H., Liu, B., Jiang, H., & Sun, X. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12039 · Cited by 72
Kuramoto, J., Arai, E., Tian, Y., Funahashi, N., Hiramoto, M., Nammo, T., Nozaki, Y., Takahashi, Y., Ito, N., Shibuya, A., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx005 · Cited by 72
Targeting Chromatin Remodeling for Cancer Therapy
Kaur, J., Daoud, A., & Eblen, S. T. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666190215112915 · Cited by 71
Wang, C., Ke, S., Li, M., Lin, C., Liu, X., & Pan, Q. (2019) · Molecular Genetics and Genomics · doi:10.1007/s00438-019-01620-5 · Cited by 71
Hua, D., Hu, Y., Wu, Y.-Y., Cheng, Z.-H., Yu, J., Du, X., & Huang, Z. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.05.001 · Cited by 62
Epigenetic landscape influences the liver cancer genome architecture
Hama, N., Totoki, Y., Miura, F., Tatsuno, K., Saito-Adachi, M., Nakamura, H., Arai, Y., Hosoda, F., Urushidate, T., Ohashi, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03999-y · Cited by 60
Wijetunga, N. A., Pascual, M., Tozour, J. N., Delahaye, F., Alani, M. T., Adeyeye, M., Wolkoff, A. W., Verma, A. K., & Greally, J. M. (2016) · Oncogene · doi:10.1038/onc.2016.340 · Cited by 58
Chen, D., Zhang, C., Lin, J., Song, X., & Wang, H. (2018) · Cancer Management and Research · doi:10.2147/cmar.s166740 · Cited by 58
Shao, F., Yang, X., Wang, W., Wang, J., Guo, W., Feng, X., Shi, S., Xue, Q., Gao, S., Gao, Y., et al. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0401-9 · Cited by 54
Li, S.-G., Peng, F., Ning, Y., Jiang, P., Peng, J., Ding, X., Zhang, J., Jiang, T., & Xiang, S. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29477 · Cited by 53
He, B., Dai, L., Zhang, X., Chen, D., Wu, J., Feng, X., Zhang, Y., Xie, H., Zhou, L., Wu, J., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27661 · Cited by 52
Bao, J., Chen, X., Hou, Y., Kang, G.-L., Li, Q., & Xu, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.079 · Cited by 51
Wang, X. Q., Ng, R. K., Ming, X., Zhang, W., Chen, L., Chu, A. C. Y., Pang, R. W. C., Lo, C. M., Tsao, S. W., Liu, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072435 · Cited by 50
Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment
Mio, C., Bulotta, S., Russo, D., & Damante, G. (2019) · Cancers · doi:10.3390/cancers11010061 · Cited by 46
Wang, Z., Zhao, Y., Wang, Y., & Jin, C. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108932 · Cited by 46
Tian, F., Yu, C., Wu, M., Wu, X., Wan, L., & Zhu, X. (2019) · Cell Proliferation · doi:10.1111/cpr.12635 · Cited by 46
Wang, M., Gu, B., Yao, G., Li, P., & Wang, K. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.45637 · Cited by 45
Han, M., Lee, J. H., Kim, G., Lee, E., Lee, Y. R., Jang, S. Y., Lee, H. W., Chun, J. M., Han, Y. S., Yoon, J. S., et al. (2020) · Genes · doi:10.3390/genes11050545 · Cited by 44
Hepatocellular Carcinoma and Possible Chemical and Biological Causes: A Review
Erkekoğlu, P., Oral, D., Chao, M., & Kocer-Gumusel, B. (2017) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.2017020927 · Cited by 43
Li, Y., Shi, H., Yuan, J., Qiao, L., Dong, L., & Wang, Y. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13273 · Cited by 43
Alcohol-Induced Epigenetic Changes in Cancer
Dumitrescu, R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8751-1_9 · Cited by 41
Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma
Shigekawa, Y., Hayami, S., Ueno, M., Miyamoto, A., Suzaki, N., Kawai, M., Hirono, S., Okada, K., Hamamoto, R., & Yamaue, H. (2018) · Oncotarget · doi:10.18632/oncotarget.26144 · Cited by 41
The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma
Poté, N., Cros, J. F., Laouirem, S., Raffenne, J., Negrão, M., Albuquerque, M., Bédossa, P., Ferreira, M. G., Ait‐Si‐Ali, S., Fior, R., et al. (2020) · Liver International · doi:10.1111/liv.14381 · Cited by 39
Zhao, B., Ke, K., Wang, Y., Wang, F., Shi, Y., Zheng, X., Yang, X., Liu, X., & Liu, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00223-6 · Cited by 39
The Emerging Role of Histone Demethylases in Renal Cell Carcinoma
Guo, X., & Zhang, Q. (2017) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.2017.56 · Cited by 37
Involvement of H19/miR‐326 axis in hepatocellular carcinoma development through modulating TWIST1
Wei, L., Li, L., Lu, C., Liu, J., Chen, Y., & Wu, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27319 · Cited by 36
Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer
Zhao, J., Gray, S. G., Greene, C. M., & Lawless, M. W. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1568870 · Cited by 35
The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma
Ghafouri‐Fard, S., Gholipour, M., Hussen, B. M., & Taheri, M. N. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.649107 · Cited by 34
Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis
Chen, S., Zhang, Y., Wu, X., Zhang, C., & Li, G. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/8410195 · Cited by 30
Yang, J., Sheng, Y., Wei, J., Gao, X., Zhu, Y., Jia, H., Dong, Q., & Qin, L. (2018) · BioMed Research International · doi:10.1155/2018/4793971 · Cited by 29
Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma
Jiang, H., Zhang, X., Tao, Y., Liang, S., Jiang, Q., Yu, Y., Cai, F., & Ma, L. (2016) · Oncotarget · doi:10.18632/oncotarget.14096 · Cited by 18
Huang, X., Yang, C. G., Wang, J., Sun, T., & Xiong, H. (2020) · Aging · doi:10.18632/aging.102923 · Cited by 16
Zhang, M., Dong, X., Zhang, D., Chen, X., & Zhu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.13891 · Cited by 14
Li, J., Li, Y., Wu, X., & Li, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.10261 · Cited by 11
Jeltsch, A., Broche, J., & Bashtrykov, P. (2019) · Genes · doi:10.3390/genes10050388 · Cited by 10
Tang, B., Qi, G., Tang, F., Yuan, S., Wang, Z., Liang, X., Li, B., Yu, S., Liu, J., Huang, Q., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27470 · Cited by 2
Cited by
Wu, T., Liao, L., Wu, T., Chen, S., Yi, Q., & Xu, M. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2283328 · Cited by 20
Metadata
- Authors
- Nagaraju, G. P., Dariya, B., Kasa, P., Peela, S., & El-Rayes, B. F.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2022-11
- Volume
- 86
- Issue
- Pt 3
- Pages
- 622-632
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W3186287941
- Cited by
- 339
- References
- 137
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.